Literature DB >> 3505338

Disposition of homovanillic acid in the primate.

A L Miller1, R W Keenan, J W Maas, R H Asch.   

Abstract

Prior studies have shown that homovanillic acid is the principal metabolite of dopamine in the primate central nervous system (CNS). In studies of primates given deuterated homovanillic acid systemically, however, only 50% of the administered amounts have been recovered in the urine over the next 4-48 hr. These findings have left it unclear whether there is a slowly turning-over compartment of homovanillic acid, conversion of homovanillic acid to another compound, or excretion of homovanillic acid from the body by a nonrenal route. We synthesized [3H]homovanillic acid and administered it intravenously to four rhesus monkeys. Over the subsequent 4 hr, 94.9 +/- 8.9% (SD) of the administered radioactivity was recovered in the urine, almost entirely as homovanillic acid. These results are consistent with the interpretation that, in primates, there is not a major body pool of homovanillic acid with slow turnover, nor is metabolism to other compounds significant, nor is there evidence for nonrenal excretion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3505338     DOI: 10.1007/bf00999612

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  5 in total

1.  Regional distribution of dopamine metabolites in human and primate brain.

Authors:  N G Bacopoulos; J W Maas; S E Hattox; R H Roth
Journal:  Commun Psychopharmacol       Date:  1978

2.  A direct method for determining dopamine synthesis and output of dopamine metabolites from brain in awake animals.

Authors:  J W Maas; S E Hattox; D M Martin; D H Landis
Journal:  J Neurochem       Date:  1979-03       Impact factor: 5.372

3.  Determination of homovanillic acid turnover in man.

Authors:  E Anggård; T Lewander; B Sjöquist
Journal:  Life Sci       Date:  1974-07-01       Impact factor: 5.037

4.  Kinetics of homovanillic acid and determination of its production rate in humans.

Authors:  M A Elchisak; R J Polinsky; M H Ebert; I J Kopin
Journal:  J Neurochem       Date:  1982-02       Impact factor: 5.372

5.  Contribution of plasma homovanillic acid (HVA) to urine and cerebrospinal fluid HVA in the monkey and its pharmacokinetic disposition.

Authors:  M A Elchisak; R J Polinsky; M H Ebert; K J Powers; I J Kopin
Journal:  Life Sci       Date:  1978-12-04       Impact factor: 5.037

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.